Skip to main content
Screener/Healthcare/Biotechnology

SRPT — Sarepta Therapeutics, Inc.

NASDAQ
$19.93-0.80 (-3.84%)
Mid CapUnder $20HealthcareLow BetaMost Profitable
$14.68
$25.32
$19.88
$20.89
EPS (TTM)$-0.96
P/E Ratio-3.09
Dividend Yield—
Market Cap$2.21B
Volume1.47M
Prev Close$20.72
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$730.8M$331.0M$2.880.0%45.3%
Q4 '25$442.9M-$282.8M$-3.9310.0%-63.9%
Q3 '25$399.4M-$179.9M$-1.8062.2%-45.1%
Q2 '25$611.1M$196.9M$1.8975.0%32.2%
Q1 '25$744.9M-$447.5M$-4.6081.5%-60.1%
Q4 '24$658.4M$159.0M$1.5079.9%24.2%
Q3 '24$467.2M$33.6M$0.3380.4%7.2%
Q2 '24$362.9M$6.5M$0.0787.7%1.8%
Get Your Daily Market Recap